Protein tyrosine phosphatase receptor U (PTPRU) is required for glioma growth and motility

Zhichuan Zhu1, Yongjie Liu1, Kui Li1

  • 1School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China, Department of Neurosurgery, Shanghai Neurosurgical Center, Huashan Hospital, Fudan University, Shanghai 200030, China and Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China.

Carcinogenesis
|May 31, 2014
PubMed

Insights

The protein tyrosine phosphatase receptor U (PTPRU) promotes glioma progression by affecting beta-catenin and focal adhesion signaling. Knockdown of PTPRU suppressed tumor growth and spread in preclinical models.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer research

Background:

  • The protein tyrosine phosphatase receptor U (PTPRU) typically inhibits cancer cell adhesion and proliferation.
  • Its role in glioma, a primary brain tumor, remains largely uncharacterized.

Purpose of the Study:

  • To investigate the function and expression of PTPRU and its isoforms in glioma.
  • To determine the impact of PTPRU on glioma cell behavior and tumor progression.

Main Methods:

  • Analysis of PTPRU expression in glioma tissues and cell lines.
  • Short hairpin RNA (shRNA) mediated knockdown of PTPRU in vitro and in vivo.
  • Assessment of cell proliferation, survival, invasion, migration, adhesion, and tube formation.
  • Evaluation of beta-catenin and c-Cbl phosphorylation and transcriptional activity.
  • Analysis of focal adhesion protein stability.

Main Results:

  • Non-full-length PTPRU isoforms, particularly nuclear-localized ones, are highly expressed in glioma and correlate with malignancy grade.
  • PTPRU knockdown inhibited glioma cell proliferation, survival, invasion, migration, adhesion, and vasculogenic tube formation in vitro.
  • PTPRU knockdown suppressed intracranial tumor progression in vivo.
  • PTPRU depletion reduced beta-catenin tyrosine phosphorylation and transcriptional activity, and increased c-Cbl tyrosine phosphorylation.
  • PTPRU knockdown led to destabilization of focal adhesion proteins.

Conclusions:

  • Endogenous PTPRU promotes glioma progression through its influence on beta-catenin and focal adhesion signaling pathways.
  • Targeting PTPRU may represent a novel therapeutic strategy for glioma.

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K